$25M, multi-year commitment builds on
Walgreens efforts to improve the health and well-being of people
living with cancer nationwide
Walgreens announced today a new collaboration with Susan G.
Komen and The Leukemia & Lymphoma Society to enable research in
tough-to-treat cancers and increase access to care with a pledge to
contribute more than $25 million to the organizations,
collectively, over the next five years. Through a combination of
corporate donations and in-store fundraising, the commitment will
enable new research in metastatic breast and pediatric blood
cancers, as well as increase access, treatment and support services
for those living with these diseases.
“At Walgreens, we see the devastating impact of a cancer
diagnosis and the challenges people living with cancer and their
caregivers face in one of the toughest journeys of their lives,”
said Richard Ashworth, Walgreens president of operations. “By
collaborating with Susan G. Komen and The Leukemia & Lymphoma
Society, we aim to advance critical needs in research, expand
prevention programs and help families with the everyday challenges
of living with cancer.”
Walgreens customers can get involved by donating to the
organizations during checkout at the more than 9,500 U.S. Walgreens
retail pharmacy locations November 3 through 17. The Leukemia &
Lymphoma Society and Susan G. Komen are committed to supporting
patient services and increasing access to screening and treatments
locally and nationally. All donations Walgreens receives in
November will be split equally between the two organizations.
“Susan G. Komen is thankful for the support of Walgreens and
their customers and excited about the potential of this
collaboration to accelerate the pace of research discovery,
particularly as it relates to understanding and combating why
breast cancers recur and become metastatic,” said Paula Schneider,
CEO, Susan G. Komen. “Thanks to this partnership, we will be able
to help support people touched by breast cancer today, while we
spur the development of more effective treatments.”
According to Louis DeGennaro, Ph.D., LLS President and CEO, “Our
partnership with Walgreens is setting a new standard for what
nonprofits and industry can do through collaboration to help more
patients. Our investment of nearly $1.3 billion in cancer research
is moving the needle, but new therapies can’t help patients who
don’t have access to them. Through this partnership, we aim to
reach more patients with critical support and services, in their
communities.”
Breast cancer and blood cancers are complex to treat and remain
prevalent in the United States. Currently, more than 3.8 million
people living in the U.S. today have been treated for or are living
with breast cancer – the most commonly diagnosed cancer in women –
and nearly 1.4 million are living with or in remission from blood
cancer in the United States.
In support of meeting the critical needs of their communities,
Susan G. Komen and The Leukemia & Lymphoma Society will focus
on:
- Susan G. Komen: Accelerating the pace of research discovery,
particularly as it relates to understanding and combating breast
cancer recurrence and metastasis, and will support people facing
breast cancer today with trustworthy information and by helping
them overcome barriers to timely, high-quality health care.
- The Leukemia & Lymphoma Society: Accelerating the delivery
of cancer treatment advances to pediatric patients and help
patients, caregivers and survivors with the financial, emotional
and psychological effects of cancer and its treatment.
Walgreens is supporting cancer patients through strategic
collaborations with leading cancer organizations, specialized
training to enable pharmacists to best serve those battling the
disease and a suite of support offerings available through
Walgreens more than 300 community-based specialty pharmacies.
Earlier this year, Walgreens launched Feel More Like You™. The
program offers an integrated approach to cancer care with specially
trained Walgreens beauty consultants and pharmacists working in
select stores to provide personalized expertise and support to
people living with cancer. Most recently as part of Feel More Like
You, Walgreens created a ten-part podcast that explores how living
with cancer not only impacts health, but identity. With a panel of
experts, the first-of-its kind podcast offers advice on what to
expect during cancer treatment, and personal stories to help
individuals feel more like themselves.
Walgreens and its parent company Walgreens Boots Alliance (WBA)
are committed to improving societal health and wellbeing around the
world. In May, WBA announced the transatlantic “Collaboration for
Cancer Prevention, Research and Support” aimed to develop and
facilitate innovative cancer research in the U.S. and Europe, and
to share best practices to improve patient care and support. The
transatlantic effort and research collaboration includes the
European Organization for Research and Treatment of Cancer (EORTC),
U.K.’s Macmillan Cancer Support, Susan G. Komen, and The Leukemia
& Lymphoma Society. Walgreens Boots Alliance focuses on three
priorities in efforts to support cancer programs: working with
organizations that advance research, expanding prevention programs
and assisting people living with cancer and their loved ones.
About Susan G. Komen
Susan G. Komen® is the world’s leading nonprofit breast cancer
organization, working to save lives and end breast cancer forever.
Komen has an unmatched, comprehensive 360-degree approach to
fighting this disease across all fronts and supporting millions of
people in the U.S. and in countries worldwide. We advocate for
patients, drive research breakthroughs, improve access to
high-quality care, offer direct patient support and empower people
with trustworthy information. Founded by Nancy G. Brinker, who
promised her sister, Susan G. Komen, that she would end the disease
that claimed Suzy’s life, Komen remains committed to supporting
those affected by breast cancer today, while tirelessly searching
for tomorrow’s cures.
About The Leukemia and Lymphoma Society
The Leukemia & Lymphoma Society® (LLS) is a global leader in
the fight against cancer. The LLS mission: Cure leukemia, lymphoma,
Hodgkin's disease and myeloma, and improve the quality of life of
patients and their families. LLS funds lifesaving blood cancer
research around the world, provides free information and support
services, and is the voice for all blood cancer patients seeking
access to quality, affordable, coordinated care.
Founded in 1949 and headquartered in Rye Brook, NY, LLS has
chapters throughout the United States and Canada. To learn more,
visit www.LLS.org. Patients should contact the Information Resource
Center at (800) 955-4572, Monday through Friday, 9 a.m. to 9 p.m.
ET.
For additional information visit www.lls.org/lls-newsnetwork.
Follow us on Facebook, Twitter, and Instagram.
About Walgreens
Walgreens (walgreens.com), one of the nation's largest drugstore
chains, is included in the Retail Pharmacy USA Division of
Walgreens Boots Alliance, Inc. (NASDAQ: WBA), the first global
pharmacy-led, health and wellbeing enterprise. Approximately 8
million customers interact with Walgreens in stores and online each
day, using the most convenient, multichannel access to consumer
goods and services and trusted, cost-effective pharmacy, health and
wellness services and advice. As of August 31, 2018, Walgreens
operates 9,560 drugstores with a presence in all 50 states, the
District of Columbia, Puerto Rico and the U.S. Virgin Islands,
along with its omnichannel business, Walgreens.com. Approximately
400 Walgreens stores offer Healthcare Clinic or other provider
retail clinic services.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20191022005311/en/
Walgreens Contact: Rebekah Pajak Phone: 224-214-8179
rebekah.pajak@walgreens.com
Susan G. Komen Contact: Sean Tuffnell Phone: 972-855-4374
STuffnell@komen.org
The Leukemia & Lymphoma Society Contact : Marcie
Klein Phone: 914-821-8205 Marcie.Klein@lls.org
http://news.walgreens.com @WalgreensNews
facebook.com/Walgreens
Walgreens Boots Alliance (NASDAQ:WBA)
Historical Stock Chart
From Apr 2024 to May 2024
Walgreens Boots Alliance (NASDAQ:WBA)
Historical Stock Chart
From May 2023 to May 2024